ADVM stock touches 52-week low at $3.95 amid sharp annual decline
Adverum Biotechnologies Inc. (NASDAQ:ADVM) stock has reached a 52-week low, dipping to $3.95, with a market capitalization of just $83.2 million. According to InvestingPro analysis, the company faces ...
Bernstein raises Confluent stock price target to $35 on strong Q4
Bernstein analysts increased their price target for Confluent Inc (NASDAQ:CFLT) shares to $35 from the previous $33, while ...